Structure-Based Design of a Potent Purine-Based Cyclin-Dependent Kinase Inhibitor
Davies, T.G., Bentley, J., Arris, C.E., Boyle, F.T., Curtin, N.J., Endicott, J.A., Gibson, A.E., Golding, B.T., Griffin, R.J., Hardcastle, I.R., Jewsbury, P., Johnson, L.N., Mesguiche, V., Newell, D.R., Noble, M.E.M., Tucker, J.A., Wang, L., Whitfield, H.J.(2002) Nat Struct Biol 9: 745
- PubMed: 12244298 
- DOI: 10.1038/nsb842
- Primary Citation of Related Structures:  
1H1P, 1H1Q, 1H1R, 1H1S - PubMed Abstract: 
Aberrant control of cyclin-dependent kinases (CDKs) is a central feature of the molecular pathology of cancer. Iterative structure-based design was used to optimize the ATP- competitive inhibition of CDK1 and CDK2 by O(6)-cyclohexylmethylguanines, resulting in O(6)-cyclohexylmethyl-2-(4'- sulfamoylanilino)purine ...